TB Genome Annotation Portal

Rv1373 (-)

• Current annotations:
  • TBCAP: (community-based annotations - see table at bottom of page)
  • TBDB: glycolipid sulfotransferase
  • REFSEQ: glycolipid sulfotransferase
  • PATRIC: Glycolipid sulfotransferase
  • TUBERCULIST: Glycolipid sulfotransferase
  • NCBI: Glycolipid sulfotransferase
  • updated information (H37Rv4):
    • gene name: stf2
    • function: sulfotransferase
    • reference: Mougous (2002) PMID: 12144918
• Type: Not Target
• Start: 1546012
• End: 1546992
• Operon:


• Trans-membrane region:
  
• Role: IV.H - Miscellaneous transferases
• GO terms:
  • GO:0046506 - sulfolipid biosynthetic process (Uniprot)
  • GO:0016740 - transferase activity (Uniprot)
  • GO:0008146 - sulfotransferase activity (Uniprot)
• Reaction(s) (based on iSM810 metabolic model):
  • TRE[c] + PAPS[c] -> PAP[c] + TRE[S][c]
• Gene Expression Profile (Transcriptional Responses to Drugs; Boshoff et al, 2004)
• Gene Modules extracted from cluster analysis of 249 transcriptomic datasets using ICA
• Orthologs among selected mycobacteria
• Protein structure:
• Search for Homologs in PDB
• Top 10 Homologs in PDB (as of Nov 2020): (none with >35% aa id)
• Links to additional information on Rv1373:
  • KEGG - nucleotide and amino acid sequences of gene
  • Mycobrowser
  • PATRIC
  • BioCyc
  • Systems Biology
  • TBDB (updated)
  • Phyre2 structure prediction, model: final.casp.pdb (from Mao et al, 2013)
  • UniProt
  • AlphaFold model
  • Vulnerability = 0.36 (from Jeremy Rock's lab)

Amino Acid Sequence

MNSEHPMTDRVVYRSLMADNLRWDALQLRDGDIIISAPSKSGLTWTQRLVSLLVFDGPDLPGPLSTVSPWLDQTIRPIEEVVATLDAQQHRRFIKTHTPL
DGLVLDDRVSYICVGRDPRDAAVSMLYQSANMNEDRMRILHEAVVPFHERIAPPFAELGHARSPTEEFRDWMEGPNQPPPGIGFTHLKGIGTLANILHQL
GTVWVRRHLPNVALFHYADYQADLAGELLRPARVLGIAATRDRARDLAQYATLDAMRSRASEIAPNTTDGIWHSDERFFRRGGSGDWQQFFTEAEHLRYY
HRINQLAPPDLLAWAHEGRRGYDPAN

Additional Information

sft2

Mougous...Bertozzi (2004) NSMB
http://www.nature.com/nsmb/journal/v11/n8/full/nsmb802.html

Sulfotransferases and Sulfatases in Mycobacteria
http://www.sciencedirect.com/science/article/pii/S1074552102001758

Analysis of Positive Selection in Clinical Isolates *new*

• Analysis of dN/dS (omega) in two collections of Mtb clinical isolates using GenomegaMap (Window model) (see description of methods)
  • Moldova: 2,057 clinical isolates
  • global set: 5,195 clinical isolates from 15 other countries
• In the omega plots, the black line shows the mean estimate of omega (dN/dS) at each codon, and the blue lines are the bounds for the 95% credible interval (95%CI, from MCMC sampling).
• A gene is under significant positive selection if the lower-bound of the 95%CI of omega (lower blue line) exceeds 1.0 at any codon.

	Moldova (2,057)	global set (5,195)
under significant positive selection?	NO	NO
omega peak height (95%CI lower bound)	2.31 (0.65)	1.09 (0.5)
codons under selection
omega plots
genetic variants*	link	link
statistics at each codon	link	link